Zanidatamab for treating HER2-positive advanced biliary tract cancer after 1 or more systemic treatments [ID6388] Technology appraisal guidance TBC Zanubrutinib for untreated chronic lymphocytic ...
Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia TA29 26 September 2001 26 September 2001 Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone ...